Metacrine MTCR
$ 0.49
0.0%
Quarterly report 2022-Q3
added 11-14-2022
Country |
USA |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Ms. Trisha M. Millican |
Employees in the company |
- |
Shares |
27.2 M |
Market Cap[1] |
$ 24.2 M |
EBITDA (LTM) |
$ -41.1 M |
P/E (LTM) |
-0.38 |
P/S (LTM) |
- |
EPS (LTM) |
-1.28 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.